ArticleCureus2024
The Impact of Lesser Trochanter Displacement on Hip Flexor Strength Recovery in Patients With Trochanteric Fracture.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTrochanteric fractures (TFs) are common in older individuals and are expected to increase with Japan's aging population. These fractures often result in poor long-term outcomes, such as decreased independent walking and reduced hospital discharge rates. A significant aspect of TF involves displacement of the lesser trochanter (LT), which can weaken hip flexor muscles and potentially affect the recovery of activities of daily living (ADLs), including walking. Previous research has shown conflicting results regarding the effect of lesser trochanteric displacement on hip function and walking ability. This study aimed to determine whether displacement of the LT affects the recovery of hip flexor strength and walking ability at discharge in patients with TF.
methodsThis prospective cohort study included 29 patients with TF admitted to a rehabilitation hospital between April 2023 and June 2024. The patients were classified into two groups: the LT displacement and the non-LT (NLT) displacement groups. Muscle strength (hip flexion, abduction, and knee extension) was measured using a handheld dynamometer. Walking ability assessments included gait speed, timed up-and-go test (TUG), 6-minute walk test (6 MWT), and functional ambulation category (FAC). Cognitive function was evaluated using the Hasegawa Dementia Rating Scale-Revised (HDS-R). Statistical analyses included repeated-measures analysis of variance (ANOVA) for muscle strength comparisons over time, with adjustments for violations of sphericity using the Greenhouse-Geisser correction.
resultsThere were no significant differences between the LT and NLT groups in terms of demographic characteristics such as age, sex, or cognitive function. Repeated-measures ANOVA revealed a significant difference in hip flexor strength on the injured side between the groups, with the LT group showing persistent weakness until discharge. Significant improvements were noted in hip abduction and knee extension strength on the injured side, although no group differences were observed. Post-hoc analysis indicated significant strength improvements over time, particularly between admission and discharge, for most muscle groups, except for hip flexor strength in the LT group.
conclusionLesser trochanteric displacement in patients with TF resulted in a specific decline in hip flexor strength on the injured side, which persisted until discharge. However, no significant impact on walking ability was observed, likely because of compensatory mechanisms involving other muscles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.